Calcium Gluconate Dosing for Hyperkalemia
For acute hyperkalemia with ECG changes, administer 10 mL of 10% calcium gluconate (1000 mg or 93 mg elemental calcium) intravenously over 2-5 minutes in adults, and 100 mg/minute (maximum) in pediatric patients, with continuous ECG monitoring. 1
Adult Dosing
Standard dose: 1000-2000 mg (10-20 mL of 10% solution) IV push over 2-5 minutes 2, 1
- Maximum infusion rate: Do not exceed 200 mg/minute 1
- Onset of action: 1-3 minutes 2
- Duration: Transient effect only
- Repeat dosing: If no ECG improvement within 5-10 minutes, repeat the dose 2
Critical Administration Details
The FDA label is explicit: dilute calcium gluconate in 5% dextrose or normal saline to a concentration of 10-50 mg/mL for bolus administration 1. However, in emergency situations with severe ECG changes (wide QRS, sine wave pattern), rapid undiluted push may be necessary while monitoring continuously 1.
Pediatric Dosing
Dose: 100 mg/minute maximum infusion rate 1
- Dilute to 10-50 mg/mL concentration before administration 1
- Continuous ECG monitoring is mandatory 1
- Same repeat dosing principles as adults apply
Mechanism and Limitations
Calcium does NOT lower serum potassium - it only provides cardiac membrane protection 2. Recent evidence challenges the traditional "membrane stabilization" theory, suggesting calcium works through calcium-dependent conduction rather than restoring resting membrane potential 3. Regardless of mechanism, calcium's effect is purely cardioprotective and temporary.
When to Use Calcium
Calcium is indicated specifically for:
- ECG changes (peaked T waves, prolonged QRS, sine wave pattern) 2, 4
- Severe hyperkalemia (K+ >6.0 mEq/L with ECG changes) 5
Important caveat: Absent or atypical ECG changes do not exclude the need for treatment 5. However, recent systematic review evidence found no clinical benefit of calcium for hyperkalemia outcomes 6, and calcium was only effective for rhythm disorders, not non-rhythm ECG changes 7. This suggests calcium should be reserved for patients with actual arrhythmias or severe conduction abnormalities, not routinely given for all hyperkalemia.
Critical Safety Warnings
Cardiac Glycoside Interaction
Avoid calcium in patients on digoxin - hypercalcemia dramatically increases digoxin toxicity risk 1. If absolutely necessary, give slowly in small amounts with continuous ECG monitoring 1.
Ceftriaxone Contraindication
Absolutely contraindicated with ceftriaxone in neonates ≤28 days due to fatal ceftriaxone-calcium precipitates causing pulmonary and renal emboli 1. In patients >28 days, flush lines thoroughly between medications and never use Y-site administration 1.
Extravasation Risk
Calcium causes severe tissue necrosis and calcinosis cutis if extravasated 1. Use secure IV access only. If extravasation occurs, stop immediately 1.
Rapid Administration Risks
Rapid bolus causes vasodilation, hypotension, bradycardia, cardiac arrhythmias, syncope, and cardiac arrest 1. This is why the 200 mg/minute maximum rate exists - though in cardiac arrest from hyperkalemia, this limit may need to be exceeded.
Special Populations
Renal impairment: Start at lowest recommended dose and monitor calcium levels every 4 hours 1. Aluminum content (up to 400 mcg/L) poses toxicity risk with prolonged use, especially in premature neonates 1.
Cardiac arrest: Use 10 mL calcium chloride instead of gluconate for faster effect (calcium chloride provides 3x more elemental calcium) 8.
Monitoring Requirements
- Continuous ECG during administration 1
- Serum calcium every 4-6 hours during intermittent infusions 1
- Serum calcium every 1-4 hours during continuous infusion 1
Integration with Complete Hyperkalemia Management
Calcium is only the first step. Simultaneously initiate:
- Insulin + glucose (10 units regular insulin + 50 mL 50% dextrose) - most effective for K+ lowering 2, 5, 6
- Inhaled albuterol 10-20 mg nebulized 2, 5, 6
- Loop diuretics for renal K+ excretion 2, 4
- Hemodialysis for definitive removal if severe 2, 4
Avoid sodium bicarbonate - evidence shows no efficacy as potassium-lowering agent when used alone 5, 6.